IBC Life Sciences’ 22nd International Antibody Development & Production Conference to Anchor Biopharmaceutical Development & Production Week -- March 2-6, 2009

WESTBOROUGH, MA--(Marketwire - February 04, 2009) - IBC is pleased to hold its 22nd International Antibody Development & Production Conference in Carlsbad, California on March 4-6, 2009.

Antibody Development & Production is the anchor conference for IBC’s Biopharmaceutical Development & Production Week which includes five conferences focused on these specific biopharmaceutical disciplines: antibody development and production, process validation, technology transfer, outsourcing manufacturing and non-antibody protein therapeutics.

The Antibody Development & Production conference provides the latest scientific and technical approaches to accelerating the development of robust processes across the spectrum of upstream and downstream processing.

Antibody Development & Production features three keynote presentations:

-- How do We Get to 30g/L Using Fed-Batch Technology? What are the Limitations? Thomas Ryll, Ph.D., Director of Cell Culture Development, Biogen Idec -- Thoughts from the New Kids on the Biotherapeutics Block Rick Rutter, Ph.D., Vice President, Pharmaceutical Sciences, Biologics, Pfizer, Inc. -- Next Generation Commercial Processes Timothy S. Charlebois, Ph.D., Director, Cell & Molecular Sciences, Wyeth BioPharma 

In addition, IBC has expanded this program to include strategy discussion forums, interactive workshops and panel discussions that will provide valuable and uncensored insight on today’s most critical topics, including:

-- Genomics, Proteomics and Metabalomics: Applications to Antibody Production -- Protein A Capture - Perception and Reality -- Alternative Purification Methods - Promise or Over-Promise? -- Future of Continuous Downstream Processing -- Can Downstream Processing Keep Pace Economically with Cell Culture? -- Chemically Defined vs. Non-Defined Additives -- Hydrolysates and Lot-to-Lot Variability 

This week-long event provides biopharmaceutical professionals the opportunity to network face-to-face with 700 industry peers and is comprised of over 120 presentations that include exclusive case studies, interactive workshop sessions, industry panels, and strategic discussion groups.

Attendees may choose to attend one conference or attend for the week with the dual conference pass. This event also includes an exhibit hall, open to attendees. Complete details on these events can be found at www.IBCLifeSciences.com/bdpweek.

Writers and editors are encouraged to attend. For a press pass please contact Dawn O’Connor at doconnor@ibcusa.com

IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. For more information, visit www.IBCLifeSciences.com.